1. Ask the Psoriasis Expert

2. Psoriasis in 2018 It Was a Very Good Year

3. Topical Treatments

4. HP/TAZ Fixed Combination Study Design

5. HP/TAZ Fixed Combination Lotion Efficacy

6. HP 0.01% Lotion Phase 3 Trials

7. MC2-01 Cal BDP Cream PAD

8. How Will New Topical Treatments Impact Clinical Practice?

9. Tildrakizumab ReSURFACE Trials

10. Tildrakizumab in Patients With Inadequate Response to Etanercept at Week 28

11. Brodalumab in Patients Who Failed IL-17A Agents

12. Risankizumab UltIMMA Trials

13. Risankizumab Efficacy

14. Bimekizumab BE ABLE Phase 2 Trial

15. Mirikizumab 52-Week Efficacy in PASI 90 Nonresponders at Week 16

16. Oral TYK-2 Inhibitor Phase 2 Trial

17. How Will New Targeted Agents Fit Into Practice?

18. Comorbid Psoriatic Arthritis

19. Comorbid Inflammatory Bowel Disease

20. Pregnancy and Nursing Mothers

21. Go Team!

22. Concluding Remarks

23. Abbreviations